1 947 848 145 762 101 Luminal androgen receptor triple-negative breast cancer (LAR) 122 Adenocarcinoma of the lung 102 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 101
2 610 577 38 554 126 Myelodysplastic syndromes / neoplasms (MDS) 67 Acute myeloid leukaemia 58 Luminal androgen receptor triple-negative breast cancer (LAR) 44
3 591 342 296 190 68 Non-small-cell lung cancer 126 Small-cell lung cancer 102 Lung cancer (all types) 65
4 550 444 139 353 119 Rectal cancer 116 Luminal androgen receptor triple-negative breast cancer (LAR) 74 Colorectal cancer 63
5 469 347 243 180 24 Breast cancer (all types) 70 Non-small-cell lung cancer 60 Small-cell lung cancer 60
6 457 337 103 277 103 Rectal cancer 116 Breast cancer (all types) 99 Colorectal cancer 61
7 457 280 251 140 74 Non-small-cell lung cancer 59 Small-cell lung cancer 55 Lung cancer (all types) 37
8 453 359 174 229 25 Pulmonary blastoma (adult) 46 Breast cancer (all types) 42 Prostate cancer 39
9 390 256 160 178 32 Multiple myeloma 54 Non-small-cell lung cancer 49 Small-cell lung cancer 42
10 351 257 148 171 22 Non-small-cell lung cancer 51 Small-cell lung cancer 44 Breast cancer (all types) 37
11 342 321 7 315 63 Prostate cancer 23 Rectal cancer 22 Multiple myeloma 22
12 266 135 109 81 57 Metastatic cancer (cancer that has spread) 45 Non-small-cell lung cancer 35 Small-cell lung cancer 31
13 245 162 125 87 24 Multiple myeloma 65 Prostate cancer 37 Non-small-cell lung cancer 30
14 234 181 79 126 17 Multiple myeloma 39 Relapsed or refractory multiple myeloma 27 Non-small-cell lung cancer 22
15 233 204 121 104 7 Small-cell lung cancer 34 Thyroid cancer 25 Lung cancer (all types) 22
16 203 165 69 117 6 Multiple myeloma 26 Non-small-cell lung cancer 23 Small-cell lung cancer 20
17 201 193 5 188 34 Acute myeloid leukaemia 33 Luminal androgen receptor triple-negative breast cancer (LAR) 27 Non-Hodgkin lymphoma (all types) 26
18 186 121 72 83 23 Pulmonary blastoma (adult) 42 Small-cell lung cancer 33 Lung cancer (all types) 28
19 179 165 18 154 20 Breast cancer (all types) 30 Prostate cancer 18 Multiple myeloma 12
20 Tianjin Medical University Cancer Institute and Hospital Institution
177 145 12 139 34 Small-cell lung cancer 34 Non-small-cell lung cancer 33 Lung cancer (all types) 30
21 171 152 18 144 33 Rectal cancer 18 Oesophageal cancer 18 Small-cell lung cancer 17
22 167 121 73 77 10 Non-small-cell lung cancer 35 Small-cell lung cancer 28 Lung cancer (all types) 25
23 165 132 19 122 30 Breast cancer (all types) 27 Rectal cancer 25 Oesophageal cancer 22
24 153 114 64 78 14 Breast cancer (all types) 19 Prostate cancer 19 Colorectal cancer 15
25 150 119 96 49 14 Acute lymphoblastic leukaemia 29 Luminal androgen receptor triple-negative breast cancer (LAR) 19 Neuroblastoma (paediatric) 18
26 140 114 49 78 9 Luminal androgen receptor triple-negative breast cancer (LAR) 14 Diffuse large B-cell lymphoma 12 Lung cancer (all types) 12
27 139 66 54 43 35 Small-cell lung cancer 42 Non-small-cell lung cancer 33 Lung cancer (all types) 21
28 137 110 55 78 13 Lung cancer (all types) 27 Non-small-cell lung cancer 23 Small-cell lung cancer 19
29 134 120 6 117 20 Prostate cancer 24 Pancreatic ductal adenocarcinoma 16 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 10
30 133 122 15 111 24 Multiple myeloma 27 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 15 Adenocarcinoma of the lung 15
31 128 94 76 53 10 Prostate cancer 31 Ovarian cancer 16 Endometrial cancer 14
32 123 101 47 67 8 Pulmonary blastoma (adult) 27 Non-small-cell lung cancer 17 Multiple myeloma 17
33 117 106 5 102 18 Acute myeloid leukaemia 12 Lung cancer (all types) 11 Small-cell lung cancer 11
34 114 101 64 54 7 Glioma & glioblastoma 11 Breast cancer (all types) 9 Acute myeloid leukaemia 9
35 113 72 54 42 17 Non-small-cell lung cancer 24 Small-cell lung cancer 20 Lung cancer (all types) 16
36 112 96 16 86 21 Biliary tract cancer (cholangiocarcinoma) 15 Biliary tract cancer (all types) 14 Breast cancer (all types) 12
37 111 80 52 50 18 Breast cancer (all types) 26 Prostate cancer 17 Rectal cancer 15
38 111 78 45 50 6 Non-Hodgkin lymphoma (all types) 17 Triple-negative breast cancer (TNBC) 16 Luminal androgen receptor triple-negative breast cancer (LAR) 16
39 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Cooperative group
106 91 36 63 12 Lung cancer (all types) 23 Small-cell lung cancer 21 Non-small-cell lung cancer 17
40 106 54 52 31 13 Non-small-cell lung cancer 21 Small-cell lung cancer 20 Lung cancer (all types) 13
41 The First Affiliated Hospital with Nanjing Medical University Institution
105 93 10 84 33 Breast cancer (all types) 17 Oesophageal cancer 16 Luminal androgen receptor triple-negative breast cancer (LAR) 13
42 103 93 4 91 30 Hodgkin lymphoma 17 Non-Hodgkin lymphoma (all types) 16 Luminal androgen receptor triple-negative breast cancer (LAR) 16
43 101 96 2 95 18 Breast cancer (all types) 11 Lung cancer (all types) 10 Melanoma 9
44 101 93 9 86 16 Non-small-cell lung cancer 9 Lung cancer (all types) 9 Small-cell lung cancer 8
45 Ruijin Hospital Institution
99 87 11 77 28 Non-Hodgkin lymphoma (all types) 24 Luminal androgen receptor triple-negative breast cancer (LAR) 22 Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) 13
46 97 74 49 41 3 Prostate cancer 26 Luminal androgen receptor triple-negative breast cancer (LAR) 12 Hodgkin lymphoma 7
47 96 56 35 38 22 Pulmonary blastoma (adult) 42 Non-small-cell lung cancer 19 Multiple myeloma 18
48 93 72 41 47 7 Prostate cancer 13 Bladder & urothelial cancer 7 Metastatic cancer (cancer that has spread) 5
49 92 78 43 43 7 Non-small-cell lung cancer 31 Small-cell lung cancer 23 Lung cancer (all types) 19
50 92 47 31 35 25 Small-cell lung cancer 20 Non-small-cell lung cancer 19 Colorectal cancer 9
51 Second Affiliated Hospital, Zhejiang University, School of Medicine Institution
88 71 10 66 37 Rectal cancer 16 Colon cancer (adenocarcinoma of the colon) 11 Colorectal cancer 10
52 Institute of Hematology & Blood Diseases Hospital, China Institution
83 82 8 79 35 Acute lymphoblastic leukaemia 13 Pulmonary blastoma (adult) 13 Acute myeloid leukaemia 8
53 Assistance Publique - Hôpitaux de Paris Unmapped
82 77 34 48 12 Luminal androgen receptor triple-negative breast cancer (LAR) 8 Acute lymphoblastic leukaemia 7 Pulmonary blastoma (adult) 5
54 81 43 37 28 13 Chronic lymphocytic leukaemia 23 Non-Hodgkin lymphoma (all types) 13 Mantle cell lymphoma 11
55 Zhejiang Cancer Hospital Institution
78 69 9 63 18 Small-cell lung cancer 13 Lung cancer (all types) 11 Breast cancer (all types) 10
56 76 73 10 65 5 Gastric & gastro-oesophageal junction cancer 18 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 15 Adenocarcinoma of the lung 15
57 76 66 7 64 7 Luminal androgen receptor triple-negative breast cancer (LAR) 8 Pancreatic ductal adenocarcinoma 7 Adenocarcinoma of the lung 7
58 West China Hospital Institution
76 56 13 51 16 Rectal cancer 13 Metastatic pancreatic ductal adenocarcinoma 10 Head and neck squamous cell carcinoma 8
59 76 50 42 25 15 Non-small-cell lung cancer 15 Small-cell lung cancer 12 Lung cancer (all types) 10
60 Shanghai Zhongshan Hospital Institution
75 56 11 50 13 Luminal androgen receptor triple-negative breast cancer (LAR) 18 Hepatocellular carcinoma 17 Biliary tract cancer (cholangiocarcinoma) 12
61 Henan Cancer Hospital Institution
74 69 3 67 17 Breast cancer (all types) 26 Small-cell lung cancer 14 Lung cancer (all types) 11
62 74 66 3 63 9 Small-cell lung cancer 16 Non-small-cell lung cancer 15 Lung cancer (all types) 15
63 73 47 34 28 8 Acute myeloid leukaemia 15 Gastric & gastro-oesophageal junction cancer 12 Bladder & urothelial cancer 12
64 72 55 26 39 14 Lung cancer (all types) 11 Small-cell lung cancer 9 Non-small-cell lung cancer 8
65 National Institute of Allergy and Infectious Diseases (NIAID) Institution
70 0 70 12 61 12 Luminal androgen receptor triple-negative breast cancer (LAR) 8 Pulmonary blastoma (adult) 3 Hodgkin lymphoma 2
66 68 63 1 63 8 Rectal cancer 10 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 10 Adenocarcinoma of the lung 10
67 68 38 33 22 10 Diffuse large B-cell lymphoma 17 Non-Hodgkin lymphoma (all types) 14 Non-small-cell lung cancer 12
68 66 60 4 58 15 Prostate cancer 9 Adenocarcinoma of the lung 7 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 7
69 SCRI Development Innovations, LLC Unmapped
65 64 3 61 5 Breast cancer (all types) 18 Small-cell lung cancer 10 Lung cancer (all types) 10
70 The First Affiliated Hospital of Soochow University Institution
65 64 20 54 25 Acute myeloid leukaemia 25 Acute lymphoblastic leukaemia 9 Luminal androgen receptor triple-negative breast cancer (LAR) 7
71 63 59 2 59 13 Head and neck squamous cell carcinoma 13 Squamous cell carcinoma of the lung 7 Multiple myeloma 6
72 61 59 1 58 6 Prostate cancer 7 Squamous cell carcinoma of the lung 5 Pulmonary blastoma (adult) 5
73 61 56 7 50 12 Prostate cancer 14 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 7 Adenocarcinoma of the lung 7
74 61 33 18 27 17 Small-cell lung cancer 16 Non-small-cell lung cancer 15 Breast cancer (all types) 8
75 59 54 4 51 8 Luminal androgen receptor triple-negative breast cancer (LAR) 7 Breast cancer (all types) 6 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 6
76 59 51 14 42 8 Acute lymphoblastic leukaemia 21 Acute myeloid leukaemia 8 Medulloblastoma 5
77 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Institution
59 44 5 40 17 Rectal cancer 18 Colorectal cancer 8 Gastric & gastro-oesophageal junction cancer 7
78 58 29 14 23 16 Small-cell lung cancer 16 Metastatic cancer (cancer that has spread) 8 Non-small-cell lung cancer 8
79 Merck KGaA (EMD Serono) Company
57 43 25 25 3 Non-small-cell lung cancer 10 Small-cell lung cancer 9 Lung cancer (all types) 8
80 56 50 4 47 4 Breast cancer (all types) 9 Luminal androgen receptor triple-negative breast cancer (LAR) 6 Hodgkin lymphoma 6
81 56 48 7 43 4 Bladder & urothelial cancer 8 Pancreatic ductal adenocarcinoma 8 Non-small-cell lung cancer 7
82 56 42 29 26 10 Prostate cancer 10 Non-small-cell lung cancer 7 Lung cancer (all types) 7
83 55 34 23 21 13 Non-small-cell lung cancer 11 Small-cell lung cancer 10 Colorectal cancer 7
84 54 50 7 45 6 Hodgkin lymphoma 4 Hepatocellular carcinoma 3 Breast cancer (all types) 3
85 Fujian Cancer Hospital Institution
54 45 2 43 7 Rectal cancer 16 Colorectal cancer 10 Breast cancer (all types) 5
86 54 43 17 36 13 Breast cancer (all types) 10 Colorectal cancer 8 Melanoma 6
87 53 49 11 41 4 Luminal androgen receptor triple-negative breast cancer (LAR) 9 Biliary tract cancer (cholangiocarcinoma) 6 Biliary tract cancer (all types) 6
88 Case Comprehensive Cancer Center Institution
52 49 5 46 4 Myelodysplastic syndromes / neoplasms (MDS) 7 Luminal androgen receptor triple-negative breast cancer (LAR) 5 Prostate cancer 5
89 52 19 15 14 10 Small-cell lung cancer 18 Non-small-cell lung cancer 17 Metastatic cancer (cancer that has spread) 13
90 51 50 5 47 3 Luminal androgen receptor triple-negative breast cancer (LAR) 5 Breast cancer (all types) 4 Hodgkin lymphoma 4
91 51 41 24 22 7 Acute myeloid leukaemia 6 Acute lymphoblastic leukaemia 5 Pulmonary blastoma (adult) 5
92 51 36 23 23 6 Prostate cancer 8 Lung cancer (all types) 6 Luminal androgen receptor triple-negative breast cancer (LAR) 6
93 University of California, San Francisco Institution
49 47 6 43 5 Prostate cancer 7 Glioma & glioblastoma 6 Melanoma 4
94 Weill Medical College of Cornell University Institution
49 46 3 43 7 Rectal cancer 6 Multiple myeloma 6 Chronic lymphocytic leukaemia 4
95 49 46 0 46 12 Breast cancer (all types) 9 Pancreatic ductal adenocarcinoma 5 Adenocarcinoma of the urethra (including clear cell adenocarcinoma) 4
96 Masonic Cancer Center, University of Minnesota Institution
48 47 6 47 6 Acute myeloid leukaemia 9 Myelodysplastic syndromes / neoplasms (MDS) 7 Breast cancer (all types) 4
97 48 36 22 25 4 Small-cell lung cancer 10 Lung cancer (all types) 9 Non-small-cell lung cancer 8
98 48 26 27 11 9 Non-small-cell lung cancer 21 Small-cell lung cancer 17 Lung cancer (all types) 14
99 48 19 26 16 6 Colorectal cancer 5 Prostate cancer 5 Ovarian cancer 5
100 OHSU Knight Cancer Institute Institution
47 46 0 46 6 Prostate cancer 8 Pulmonary blastoma (adult) 5 Luminal androgen receptor triple-negative breast cancer (LAR) 5